Stay updated on Psilocybin vs Escitalopram for MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.

Latest updates to the Psilocybin vs Escitalopram for MDD Clinical Trial page
- Check6 days agoChange DetectedThe page displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2 label. This is a UI/versioning update and does not affect study content or how users interact with the page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe update adds a site revision tag (Revision: v3.4.2) and removes an earlier funding-status notice (Revision: v3.4.1); these are administrative changes that do not affect study content or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedA site-wide funding-lapse notice with the NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded Show glossary option and a Revision: v3.4.0 tag, with small labeling updates to QC-related fields and the No FEAR Act data.SummaryDifference0.2%

- Check71 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; study details and user-facing content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Psilocybin vs Escitalopram for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.